CN Patent

CN107406417A — 4H‑吡咯并[3,2‑c]吡啶‑4‑酮衍生物

Assigned to Bayer Pharma AG · Expires 2017-11-28 · 8y expired

What this patent protects

式(I)的化合物，其制备方法及其作为药物的用途。

USPTO Abstract

式(I)的化合物，其制备方法及其作为药物的用途。

Drugs covered by this patent

sevabertinib (SEVABERTINIB)

Patent Metadata

Patent number: CN107406417A
Jurisdiction: CN
Classification: —
Expires: 2017-11-28
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Pharma AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.